Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil

被引:0
作者
Rogerio S Parra [1 ]
Julio MF Chebli [2 ]
Heda MBS Amarante [3 ]
Cristina Flores [4 ]
Jose ML Parente [5 ]
Odery Ramos [6 ]
Milene Fernandes [7 ]
Jose JR Rocha [1 ]
Marley R Feitosa [1 ]
Omar Feres [1 ]
Antonio S Scotton [8 ]
Rodrigo B Nones [9 ]
Murilo M Lima [10 ]
Cyrla Zaltman [11 ]
Carolina D Goncalves
Isabella M Guimaraes
Genoile O Santana [12 ]
Ligia Y Sassaki [13 ]
Rogerio S Hossne [13 ]
Mauro Bafutto [14 ]
Roberto LK Junior [15 ]
Mikaell AG Faria [15 ]
Sender J Miszputen [16 ]
Tarcia NF Gomes [17 ]
Wilson R Catapani [18 ]
Anderson A Faria [19 ]
Stella CS Souza [19 ]
Rosana F Caratin [20 ]
Juliana T Senra [20 ]
Maria LA Ferrari [19 ]
机构
[1] Department of Surgery and Anatomy, Ribeirao Preto Medical School, University of Sao Paulo
[2] Inflammatory Bowel Disease Center, Federal University of Juiz de Fora
[3] Hospital de Clinicas da Universidade Federal do Parana
[4] Hospital de Clinicas de Porto Alegre  5. Universidade Federal do Piaui  6. Hospital de Clínicas da Universidade Federal do Parana, Curitiba 
关键词
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Quality of life; Healthcare resources;
D O I
暂无
中图分类号
R574 [肠疾病];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Inflammatory bowel diseases(IBD) have been associated with a low quality of life(QoL) and a negative impact on work productivity compared to the general population.Information about disease control,patient-reported outcomes(PROs),treatment patterns and use of healthcare resources is relevant to optimizing IBD management.AIM To describe QoL and work productivity and activity impairment(WPAI),treatment patterns and use of healthcare resources among IBD patients in Brazil.METHODS A multicenter cross-sectional study included adult outpatients who were previously diagnosed with moderate to severe Crohn’s disease(CD) or ulcerative colitis(UC).At enrolment,active CD and UC were defined as having a Harvey Bradshaw Index≥8 or a CD Activity Index≥220 or calprotectin> 200 μg/g or previous colonoscopy results suggestive of inadequate control(per investigator criteria) and a 9-point partial Mayo score≥5,respectively.The PRO assessment included the QoL questionnaires SF-36 and EQ-5 D-5 L,the Inflammatory Bowel Disease Questionnaire(IBDQ),and the WPAI questionnaire.Information about healthcare resources and treatment during the previous 3 years was collected from medical records.Chi-square,Fisher’s exact and Student’s t-/Mann-Whitney U tests were used to compare PROs,treatment patterns and the use of healthcare resources by disease activity(a=0.05).RESULTS Of the 407 patients in this study(CD/UC:64.9%/35.1%,mean age 42.9/45.9 years,54.2%/56.6% female,38.3%/37.1% employed),44.7%/25.2% presented moderate-to-severe CD/UC activity,respectively,at baseline.Expressed in median values for CD/UC,respectively,the SF-36 physical component was 46.6/44.7 and the mental component was 45.2/44.2,the EQ-visual analog scale score was 80.0/70.0,and the IBDQ overall score was 164.0/165.0.Moderate to severe activity,female gender,being unemployed,a lower educational level and lower income were associated with lower QoL(P <0.05).Median work productivity impairment was 20% and 5% for CD and UC patients,respectively,and activity impairment was 30 %,the latter being higher among patients with moderate to severe disease activity compared to patients with mild or no disease activity(75.0% vs 10.0%,P <0.001).For CD/UC patients,respectively,25.4%/2.8% had at least one surgery,38.3%/19.6% were hospitalized,and 70.7%/77.6% changed IBD treatment at least once during the last 3 years.The most common treatments at baseline were biologics(75.3%)and immunosuppressants(70.9%) for CD patients and 5-AS A compounds(77.5%) for UC patients.CONCLUSION Moderate to severe IBD activity,especially among CD patients,is associated with a substantial impact on QoL,work productivity impairment and an increased number of IBD surgeries and hospitalizations in Brazil.
引用
收藏
页码:5862 / 5882
页数:21
相关论文
共 25 条
[1]   Tools for primary care management of inflammatory bowel disease:Do they exist? [J].
Alice L Bennett ;
Pia Munkholm ;
Jane M Andrews .
World Journal of Gastroenterology, 2015, 21 (15) :4457-4465
[2]  
Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil[J]. José Miguel Luz Parente,Claudio Saddy Rodrigues Coy,Viriato Campelo,Mírian Perpétua Palha Dias Parente,Leonardo Araújo Costa,Renata Mendes da Silva,Celso Stephan,José Murilo Robilotta Zeitune.World Journal of Gastroenterology. 2015(04)
[3]   Recent trends in the epidemiology of inflammatory bowel diseases:Up or down? [J].
Peter Laszlo Lakatos .
World Journal of Gastroenterology, 2006, (38) :6102-6108
[4]  
Inflammatory Bowel Disease in Latin America: A Systematic Review[J] . María Calderón,Nicole Minckas,Solange Nu?ez,Agustín Ciapponi.Value in Health Regional Issues . 2018
[5]  
Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy[J] . Rogério S. Parra,Marley R. Feitosa,Letícia C. H. Ribeiro,Lais A. Castro,José J. R. Rocha,Omar Féres,Paolo Gionchetti.Gastroenterology Research and Practice . 2018
[6]  
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J] . Siew C Ng,Hai Yun Shi,Nima Hamidi,Fox E Underwood,Whitney Tang,Eric I Benchimol,Remo Panaccione,Subrata Ghosh,Justin C Y Wu,Francis K L Chan,Joseph J Y Sung,Gilaad G Kaplan.The Lancet . 2017 (1011)
[7]  
Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014[J] . Caroline B?hler,Stephan R. Vavricka,Alain M. Schoepfer,Beat Brüngger,Oliver Reich.BMC Gastroenterology . 2017 (1)
[8]  
Drug resistance in inflammatory bowel diseases[J] . Jacques Moreau,Emmanuel Mas.Current Opinion in Pharmacology . 2015
[9]  
Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease[J] . Nicolas Williet,William J. Sandborn,Laurent Peyrin–Biroulet.Clinical Gastroenterology and Hepatology . 2014
[10]  
Determinants of health-related quality of life in Crohn’s disease: A systematic review and meta-analysis[J] . Mike van der Have,Karen S. van der Aalst,Ad A. Kaptein,Max Leenders,Peter D. Siersema,Bas Oldenburg,Herma H. Fidder.Journal of Crohn’s and Colitis . 2014 (2)